Date: September 15, 2025
Time: 12:00 pm to 1:00 pm
Track: Interactive Lunch Workshop
This session will explore emerging neurovascular mechanisms, with a focus on cellular and molecular processes at the brain barriers; the bidirectional regulation of neuroimmune activation; the development of vascular, fluid, and imaging biomarkers; and innovative therapeutic interventions for a variety of neurological diseases. Renowned speakers will present cutting-edge research on vascular and immune mechanisms in Alzheimer’s disease, multiple sclerosis, and stroke, highlighting novel therapeutic interventions, biomarkers, and clinical trial approaches to treatment.
At the conclusion of this session, attendees should be able to:
This presentation will discuss how immune factors contribute to neurovascular and neurodegenerative diseases, but also play a key role in ARIA, a complication of Abeta immunotherapy.
This presentation will discuss the communication between the brain, immune, and vascular systems as a key contributor and therapeutic target for neurological diseases.
In this presentation, Dr. Fanny Elahi will discuss her work developing novel blood-based biomarkers to determine the risk of brain degeneration across various pathologies.